The National Institutes of Health runs a training program called Innovative Programs to Enhance Research Training. Per the record, the IPERT R25 listing carries a maximum award of $500,000 and an application deadline of October 14, 2026. Its eligibility block opens with a list of Other Eligible Applicants, and the list includes this entry:
Non-domestic (non-U.S.) Entities (Foreign Organizations).
Eleven words later, the same paragraph says: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Both sentences are on the record. The listing names foreign organizations among the eligible applicants and then excludes them, without a paragraph break. Anyone who reads the list and stops reading — or any keyword search that matches the list — gets the opposite of the rule.
A listing that mentions foreign organizations is answering up to three separate questions: whether a non-U.S. organization may be the applicant, whether a U.S. applicant may have a non-U.S. component, and whether foreign components are permitted at all. They resolve independently, and only the third one varies between otherwise identical listings.
The Two Sentences That Look Like Duplicates
Read the block on the AHRQ Health Services Research Demonstration and Dissemination Grants (R18). After the same boilerplate list, per the record, it states two things:
Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Those look like the same sentence written twice. They are not. The first is about the applicant — the legal entity whose name goes on the submission. The second is about a part of a U.S. applicant that sits outside the United States: a branch, a field site, an overseas lab operated by the same organization. A U.S. university that cleared the first rule because it is a U.S. university can still be caught by the second if the work it proposed runs out of its campus abroad.
So an organization reading its own eligibility has to ask the question twice, once about itself and once about the piece of itself that will actually do the work. The AHRQ record carries a deadline of May 26, 2029; no award ceiling appears on the record, so see the listing for amounts. A long window is no help if the second sentence is the one that applies.
The Third Sentence Is the Only One That Moves
Three of these records carry a third line, and it is the line that behaves differently across programs that otherwise read identically.
On IPERT, per the record: Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
On NIH Support for Conferences and Scientific Meetings (Parent R13), per the record: Foreign components, as defined in the NIH Grants Policy Statement, are allowed. The R13’s deadline on the record is September 7, 2027; no ceiling is stated, so see the listing.
On the AHRQ R18, the line is absent altogether.
Same funder family, same template, same first two sentences, three different answers to the question an applicant with any international collaborator actually needs answered. And note what the line is doing: it points at a definition held somewhere else — the NIH Grants Policy Statement — rather than defining the term on the notice. Whether your planned arrangement is a “foreign component” is settled by that document, not by the listing you are reading or by how peripheral the arrangement feels.
That is the practical lesson for anyone working across federal grants generally. Where a notice defers to a policy statement, the notice is not the authority. It is a pointer, and the thing it points at can make a collaboration you considered minor into the reason the application is returned.
Latin America in the Title, United States in the Eligibility
The clearest case in the set is a program whose subject is explicitly another hemisphere.
NIH’s Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America is, per its own title, about setting the stage for better health outcomes across the hemisphere. It is an R01 with clinical trials not allowed, and the deadline on the record is January 7, 2027; no award figure appears, so see the listing.
Its eligibility block is the standard one. Foreign organizations are not eligible to apply. Non-U.S. components of U.S. organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
So a program about Latin American health disparities is, on the record, closed to Latin American institutions as applicants — while permitting foreign components under the policy statement’s definition. The region in the title describes where the research looks, not who may submit.
This is worth sitting with, because the inference most people draw runs the other way. A notice about a place reads like an invitation to organizations in that place. On this family of listings, subject matter and applicant eligibility are set by different parts of the document and routinely disagree. Every record in this set carries a geography of “United States” in the index, including the ones designed around work abroad — a filter on geography sorts by the funder’s country, not by who can apply.
When the Applicant Is Meant to Be Abroad
NIH does run the inverse, and it is a separate notice rather than an exception inside one.
The Emerging Global Leader Award (K43) exists, per the record, to provide research support and protected time — three to five years — to an early career research scientist from a low- or middle-income country who holds a junior faculty position at an LMIC academic or research institution, as classified by the World Bank, including low-income, lower-middle-income and upper-middle-income countries. The record states the award invites applications from LMIC scientists in any health-related discipline, proposing career development activities and a research project relevant to their own country’s health priorities, under the mentorship of both LMIC and U.S. mentors. The deadline on the record is December 3, 2026. This version is for research that does not involve leading an independent clinical trial; per the record, applicants who would lead one should apply to the companion announcement.
The structural point: when the answer to “may a non-U.S. institution be the applicant” is yes, it generally arrives as its own program with its own eligibility written around that fact — not as a permission buried in a general notice. If you are an institution outside the United States hunting for U.S. federal money, the productive search is for the programs built for you, not for general programs that might let you in. Our funder directory and knowledge base are organised around that distinction.
The Document Nobody Reading the Notice Expects
The most useful record in the set is not a funding opportunity at all.
NIH’s Fogarty International Center application page is, per the record, a guidance portal rather than a notice: it has no single deadline and no award amount, because those vary per announcement. It states that FIC does not accept unsolicited applications — applicants must find a specific notice in the NIH Guide or on Grants.gov. It lists the required registrations: eRA Commons, Grants.gov, ASSIST and SAM.gov.
And it names something the individual notices do not: a Foreign Justification requirement, which per the record applies to foreign institutions or domestic institutions with foreign components.
Read that scope again. The obligation does not attach only to applicants from outside the United States. It attaches to a U.S. organization that has any foreign component in its project — which is exactly the applicant least likely to think the international paperwork is theirs. A U.S. nonprofit sending one work package to a partner overseas has not become a foreign applicant, but on this family of programs it has acquired a justification document it will not find described on the notice it was reading.
That is the pattern worth generalising past NIH: the registration and justification burden of working across a border is frequently documented at the agency or center level, one layer up from the notice. The notice tells you whether you may. The center’s application guidance tells you what you then owe.
Outside NIH, the Border Splits Somewhere Else Entirely
Two open records show the same question cutting along different lines, which is a useful check against treating the NIH block as how funding works generally.
The U.S. Mission to the United Nations–Geneva Small Grants Program is a U.S. federal notice carrying awards of $1,000 to $100,000 on the record. It accepts proposals promoting U.S. policy priorities in the multilateral sphere — and per the record, projects should be aimed at international (not U.S.) audiences, with impact resonating in Geneva’s multilateral environment, and should be implemented by an organization or individual with a presence in Geneva and/or carried out in Geneva itself. The record names the funding as FY23 Fulbright Hays Public Diplomacy Funds, with awards subject to the availability of appropriated funds. No deadline appears on the record; see the listing.
Here the border constrains the audience and the place of performance rather than the applicant’s nationality. A U.S. organization with no Geneva presence is poorly placed, and a project serving Americans is outside the purpose.
The Commonwealth Foundation’s Individual Organisation Grants invert the frame again. Per the record, awards run $15,000 to $30,000 with a deadline of October 26, 2026, for not-for-profit civil society organisations including creative organisations delivering standalone projects across the Commonwealth. Applications must address climate and environmental justice, economic inclusion, or freedom of expression, with consideration of gender and intersectionality — and the record states a preference for Commonwealth small states. Eligibility here is membership in a treaty organisation, and the tie-breaker favours applicants from its smaller members.
Three funders, three unrelated uses of a border: nationality of the applicant, location of the audience, and membership of a bloc with a size preference inside it. None of them is inferable from the others.
What to Do With a Listing That Mentions a Border
A short protocol, derived entirely from the records above:
- Do not read the eligible-applicants list as the rule. On these records it is template text, and the operative sentences follow it. Where the two conflict, the conflict is the point: read to the end of the paragraph.
- Answer the applicant question and the component question separately. They are different sentences about different things, and clearing one says nothing about the other.
- Look for the third line, and treat its absence as unresolved. “Allowed,” “not allowed,” and nothing at all are three different states. Where it is absent, the notice has not told you.
- Check the center’s or agency’s own application guidance, not just the notice. That is where Fogarty’s Foreign Justification lives, and it binds domestic applicants too.
- Where the program is built for non-U.S. applicants, it will say so in its purpose. Search for that rather than for permission inside a general program.
None of this requires a legal reading of anything. It requires finishing the paragraph — and knowing that the paragraph is doing three jobs at once. More patterns like this one sit in our tips and resources coverage.
FAQ
Does a program about another country mean organizations in that country can apply? Not on these records. The Latin America R01 is explicitly about health disparities across the hemisphere, and per the record foreign organizations are not eligible to apply. Subject matter and applicant eligibility are set separately.
What is the difference between a foreign applicant and a foreign component? Per these records they are addressed by separate sentences. The first is about the entity submitting the application; the second is about a non-U.S. part of a U.S. applicant. A third line, where present, addresses whether foreign components are permitted, by reference to the NIH Grants Policy Statement’s definition.
Is the Foreign Justification only for applicants outside the United States? No. Per the Fogarty record, it applies to foreign institutions or domestic institutions with foreign components.
Why do these listings all show a United States geography? The geography reflects the funder, not the applicant. The K43 is designed for junior faculty at LMIC institutions and still indexes as United States, so geography is not a reliable eligibility filter.
Are the figures in this post the full terms? No. Every number here comes from the indexed record; where no award ceiling or deadline appears, we have said so and linked the listing. Confirm all terms against the funder’s own notice before you build a budget around them.
The Bottom Line
The eligibility paragraph on this family of notices contains a sentence that names foreign organizations as eligible and a sentence that excludes them, and the difference between programs lives in a third sentence that is sometimes missing. It is not ambiguity, and it is not a drafting error to work around — it is three rules sharing one paragraph, and the reader is expected to separate them. The applicants who get caught are rarely the ones who misjudged a hard case. They are the ones who stopped reading at a list.
Want these patterns as they land? Subscribe to Funding Friday, our weekly grant digest, or browse more of this analysis on the OpenGrants blog.
Last updated October 7, 2026. Every figure above is drawn from the grant record as indexed; OpenGrants does not guarantee funding outcomes, and terms change — verify against the funder’s listing before applying.